Nebivolol in High‐Risk, Obese African Americans With Stage 1 Hypertension: Effects on Blood Pressure, Vascular Compliance, and Endothelial Function
Authors:
Open Access
- 3 December 2009
- journal article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 11 (12) , 720-725
Abstract
The authors sought to determine whether nebivolol treatment results in changes in blood pressure (BP), nitric oxide bioavailability, and vascular function in obese African Americans with recently diagnosed stage 1 hypertension. Forty‐three obese, hypertensive African Americans (mean BP: systolic, 148.8±14.3 mm Hg; diastolic, 90.4±8.2 mm Hg) were treated with nebivolol (5–10 mg/d) for 8 weeks. Primary outcomes were change in systolic and diastolic BP and efficacy in reaching normotensive BP. Mean systolic BP decreased by 9.2±14 mm Hg (P<.005) and diastolic BP decreased 6.8±9 mm Hg (P<.005) with 8 weeks of therapy. Significant improvements were seen in arterial compliance with nebivolol treatment as measured by aortic augmentation index (P<.005) and time to wave reflection (P=.013). Nebivolol treatment improved endothelial function as measured by flow‐mediated dilation (P<.005). Levels of erythrocyte cellular superoxide dismutase increased with nebivolol, indirectly suggesting increased bioavailability of nitric oxide (P<.005). Monotherapy with nebivolol in obese, hypertensive African Americans results in significant systolic and diastolic BP reduction by mechanisms that include improved vascular function and compliance.Keywords
This publication has 31 references indexed in Scilit:
- Differences in healthy lifestyle characteristics between adults with prehypertension and normal blood pressureJournal Of Hypertension, 2009
- Trends in Hypertension Prevalence, Awareness, Treatment, and Control Rates in United States Adults Between 1988–1994 and 1999–2004Hypertension, 2008
- Relationship of health behavior theories with self-efficacy among insufficiently active hypertensive African–American womenPatient Education and Counseling, 2008
- Heart Disease and Stroke Statistics—2007 UpdateCirculation, 2007
- Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004Hypertension, 2007
- Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levelsJournal Of Hypertension, 2006
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Racial Differences in Risk Factors for AtherosclerosisAngiology, 1997
- Nebivolol in HypertensionJournal of Cardiovascular Pharmacology, 1993